Tobacco, electronic nicotine delivery system, nicotine replacement therapy, and cannabinoid use during pregnancy: A descriptive cross-sectional survey
The estimated prevalence of tobacco, ENDS, NRT, and cannabinoid use among the pregnant women in this survey was 7.6%, 0.8%, 0.4%, and 3.8% respectively. However, among tobacco users, only one-fourth received smoking cessation counseling intervention.
Authors
- Émeline Maisonneuve (ORCID: https://orcid.org/0000-0001-5765-4468)
- Jérôme Mathis
- Stéphanie Baggio (ORCID: https://orcid.org/0000-0002-5347-5937)
- Reto Auer (ORCID: https://orcid.org/0000-0003-4222-4849)
- Anna Schoeni (ORCID: https://orcid.org/0000-0002-2421-5925)
- Alice Panchaud (ORCID: https://orcid.org/0000-0001-6086-2401)
- Stephen P. Jenkinson (ORCID: https://orcid.org/0000-0002-8276-7082)
- Sreemanjari Kandhasamy
- Yolanda Mattmann
Institutions
- University of Bern (CH)
- University of Lucerne (CH)
- Centre universitaire de médecine générale et santé publique, Lausanne (CH)
- Spitalzentrum Centre hospitalier Biel- Bienne (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1371/journal.pone.0332961
- Primary Topic
- Smoking Behavior and Cessation
- Type
- article
- Field-Weighted Citation Impact
- 0.00